Finance News – Eli Lilly
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Financial Post Top Stories
- Financial Times
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- The Block
- The Guardian – Business
Eli Lilly stock sinks as pharma misses out on the market rally
Eli Lilly experienced a notable decline in share value as broader pharmaceutical stocks failed to benefit from the market’s upward movement, influenced by new government policies o...
Read Full Article →Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study
The superior results of Eli Lilly’s medication compared to Novo Nordisk’s in the recent trial may influence market dynamics and investor confidence within the competitive obesity t...
Read Full Article →Here’s how much extra weight is lost with Zepbound over Wegovy
A recent comparison of two popular weight-loss medications highlighted a measurable difference in effectiveness, potentially influencing market share and revenue for the companies...
Read Full Article →Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer...
Eli Lilly experienced a significant increase in sales attributed to strong demand for its weight loss and diabetes medications, yet adjusted its profit forecast following a recent...
Read Full Article →